Why Elanco Animal Health (ELAN) Is Getting Attention Now
Elanco Animal Health (ELAN) has been drawing attention after its recent share performance, with the stock down over the past month and past 3 months despite a gain over the past year.
For context, Elanco Animal Health now trades at US$22.41, with the share price slipping over the past month and quarter, while the 1 year total shareholder return of 10.83% and 3 year total shareholder return of about 13x signal that longer term momentum has been stronger than the recent pullback.
Scan opportunities like Elanco Animal Health that combine recent share price pressure with longer term momentum by reviewing our curated list of 32 high quality undervalued stocks.
Elanco Animal Health has a broad pet and farm animal portfolio and a share price that has stepped back in recent months. The real tension is simple: does the current valuation still reflect that underlying business strength?
Most Popular Narrative: 28% Undervalued
On the most followed valuation view, Elanco Animal Health screens as undervalued, with a fair value estimate of $31.21 against the last close at $22.41.
Operational focus on product launches and divestment of non core businesses like the Aqua division has enabled debt reduction and increased investment capacity, which should improve net margins and financial stability.
An emphasis on ongoing efficiency improvements, through infrastructure optimization and improved product mix, is expected to enable margin expansion from 2026 onwards, boosting long term earnings potential.
See why 12 investors see Elanco Animal Health as 28% undervalued.
Result: Fair Value of $31.21 (UNDERVALUED)
Still, the Elanco Animal Health story can break if foreign exchange pressure weighs on international revenue, or if new launches like Zenrelia and Credelio Quattro adopt more slowly than analysts expect.
Find out about the key risks to this Elanco Animal Health narrative.
Next Steps
Sentiment around Elanco Animal Health is constructive, but every investor reads the same facts differently, so it pays to move quickly and test the thesis against your own risk tolerance. To see what the optimism is built on, review the 4 key rewards.
Looking for more Elanco Animal Health style opportunities?
Do not stop with Elanco Animal Health. Use the Simply Wall St Screener to uncover other ideas that match your risk profile, income needs, and return ambitions.
- Target higher yield potential by reviewing companies in the 8 dividend fortresses that could complement Elanco Animal Health in an income focused portfolio.
- Hunt for quality at a discount through the 32 high quality undervalued stocks so you are not relying on a single stock to carry your valuation case.
- Prioritise resilience first and scan the 32 resilient stocks with low risk scores to find businesses with steadier profiles before the crowd pays attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com